SEC Form 4 · accession 0001013606-15-000025
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Janet Mary Fauls
Officer — VP Regulatory Affairs
Period of report
Mar 13, 2015
Accepted (ET)
Mar 16, 2015 · 2:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 13, 2015 | M | 15,000 | $4.36 | A | 82,422 | D | |
| Common Stock | Mar 13, 2015 | S$0 | 15,000 | $0.00 | D | 67,422 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase | $4.36 | Mar 13, 2015 | M | 15,000 | D | May 20, 2011 | May 20, 2020 | Option to Purchase | 15,000 | 9,000 | D |